Changes in Inflammatory Markers after Administration of Tocilizumab in COVID-19: A Single-Center Retrospective Study.

Although the majority of the patients who died had multiple comorbidities and developed multiorgan failure ( Table 2 ), the association of CCI values with clinical outcome did not reach statistical significance ( p = 0.10).

also in 111,027 other papers